Obesity Clinical Trial
Official title:
Evaluating a Messaging Campaign in the United States
Purpose: To evaluate reactions to and opinions of a messaging campaign.
Participants: Participants will be recruited through Prime Panels and will be US-based adults
(18 years old and older) who consumed red meat in the past 30 days.
Procedures (methods): After completing a screening question about meat consumption,
participants will review a consent form. If they select to participate in the study,
participants will be randomly assigned to view control messages, red meat-related environment
messages, or red meat-related health messages. They will be asked a series of questions about
these messages.
Participants will also be asked about grocery shopping preferences and standard demographics
questions.
Excess consumption of red and processed meat is a growing problem, especially in the United
States where meat is consumed more than three times the global average. Epidemiological
evidence for the association between excess meat intake and negative health outcomes (such as
cancer, cardiovascular disease, and type 2 diabetes) as well as negative environmental
impacts (such as pollution, overuse of resources, and carbon emissions) indicates that
reducing meat consumption should be particularly pertinent to researchers and other public
health professionals.
The potential of using widespread communication campaigns, such as Meatless Monday, to reduce
meat consumption by educating individuals on the associated health and environmental risks
appears to be promising. However, the current literature is missing information regarding
what types of messages are most effective (e.g. negative environmental messages vs. negative
health messages). To address this knowledge gap, our study will collect quantitative data in
measurable outcomes to understand effectiveness and comprehension of environmental messages
and health messages to reduce meat consumption.
Setting: This is an online study using Qualtrics, so this research does not involve talking
to human participants.
Recruitment: Participants will be recruited through Prime Panels, a survey research firm
through which participants voluntarily sign up to participate in research studies.
Informed Consent: Participants will read a written consent document that includes information
about the study's purpose, expectations, and possible risks and benefits. Participants will
acknowledge that they have read and agreed to the terms by clicking forward.
Randomization: Participants will be randomly assigned to one of three groups: 1) control
(about checking their credit score), 2) environment-focused Meatless Monday messages, or 3)
health-focused Meatless Monday messages.
Assessment: Using an online platform (Qualtrics), participants will answer a screening
question about red meat consumption. If they are eligible (consumption of red meat 1 time per
week or more), they will proceed to the main study after reading and agreeing to the written
consent form. Participants will then answer two questions about their belief in climate
change. Participants will then view four messages in their ascribed conditions. After viewing
all 4 messages, participants will answer a series of questions about the messages they
viewed. Then, participants will answer a series of demographic questions. Participants will
also answer questions about grocery shopping preferences.
Detailed description of the trial arms: This study is a three-armed between subjects' design.
Participants will be randomized to view a set of four messages either about the environmental
harms of meat production (intervention), the health harms of meat consumption (intervention),
or about checking their credit score (control). The environmental and health harms messages
were obtained from existing publicly available messages from the Meatless Monday campaign.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |